Researchers used an online English-language survey questionnaire to collect data on pharmacists from Germany and Switzerland about how their knowledge and dispensing frequency of biologics and biosimilars changed from before and after the pandemic.
Cameron Santoro
Advertisement
Articles by Cameron Santoro
Tralokinumab is the first form of atopic dermatitis treatment that targets the interleukin-13 cytokine, the main source of atopic dermatitis symptoms.
Advertisement
Latest Updated Articles
Assessing Pharmacist Attitudes on Biosimilar Dispensing Before, After COVID-19 PandemicPublished: January 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Improve Diabetes Outcomes Through Continuous Glucose Monitoring Services
2
Leading Cause of Meningitis Shifts from S. Pneumoniae to K. Pneumoniae
3
American Pharmacists Month: Evolution of Experiential Learning for Pharmacy Students
4
5 Questions With a Pharmacist: Amina Abubakar From Avant Pharmacy
5
